Brief: Iconovo Initiates Feasibility Study With Affilogic

Iconovo AB

19/06/2023 13:13

June 19 (Reuters) - Iconovo AB  ICO.ST :
    * ICONOVO INITIATES FEASIBILITY STUDY WITH AFFILOGIC FOR
DEVELOPMENT OF INHALABLE NANOFITIN®-BASED BIOTHERAPIES
    * HAS ENTERED INTO A FEASIBILITY AGREEMENT WITH AFFILOGIC
REGARDING IMPLEMENTATION OF A FEASIBILITY STUDY OF INHALABLE
AFFINITY PROTEINS NANOFITINS® IN ICONOVO'S ICOONE
    * PROJECT AIMS TO DEVELOP A NEW TREATMENT FOR LUNG DISEASES

Source text for Eikon:  ID:nMFN9bLZ8g 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))